UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

The lancet oncology, 2018-06, Vol.19 (6), p.737-746

2018

Volltextzugriff (PDF)

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

Cancers, 2021-03, Vol.13 (6), p.1383

2021

Volltextzugriff (PDF)

Thymic epithelial tumors: From biology to treatment

Cancer treatment reviews, 2020-06, Vol.86, p.102014-102014, Article 102014

2020

Volltextzugriff (PDF)

Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2019-08, Vol.111 (8), p.772-781

2019

Volltextzugriff (PDF)

Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML

Oncogene, 2022-02, Vol.41 (6), p.878-894

2022

Volltextzugriff (PDF)

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Clinical cancer research, 2021-08, Vol.27 (15), p.4311-4324

2021

Volltextzugriff (PDF)

Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5614-5627

2017

Volltextzugriff (PDF)

Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies

Cancers, 2023-06, Vol.15 (13), p.3305

2023

Volltextzugriff (PDF)

Successful treatment with avapritinib in patient with mucosal metastatic melanoma

Therapeutic advances in medical oncology, 2020-07, Vol.12, p.175883592094615

2020

Volltextzugriff (PDF)

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Journal of thoracic oncology, 2016-08, Vol.11 (8), p.1345-1356

2016

Volltextzugriff (PDF)

Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.

Breast (Edinburgh), 2024-02, Vol.73, p.103672-103672, Article 103672

2024

Volltextzugriff (PDF)

Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors

Frontiers in immunology, 2022-06, Vol.13, p.941254-941254

2022

Volltextzugriff (PDF)

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

Frontiers in immunology, 2024, Vol.15, p.1340979-1340979

2024

Volltextzugriff (PDF)

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers

Therapeutic advances in medical oncology, 2020-11, Vol.12, p.175883592097700

2020

Volltextzugriff (PDF)

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Breast (Edinburgh), 2023-06, Vol.69, p.258-264

2023

Volltextzugriff (PDF)

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

Breast cancer research : BCR, 2019-12, Vol.21 (1), p.153-153, Article 153

2019

Volltextzugriff (PDF)

Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature

Cancer treatment reviews, 2021-01, Vol.92, p.102133-102133, Article 102133

2021

Volltextzugriff (PDF)

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3494-3499

2023

Volltextzugriff (PDF)

The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers

Cancer medicine (Malden, MA), 2023-08, Vol.12 (16), p.17047-17055

2023

Volltextzugriff (PDF)

The effect of patient sex on the efficacy and safety of anticancer immunotherapy

Expert opinion on drug safety, 2021-12, Vol.20 (12), p.1535-1544

2021

Volltextzugriff (PDF)

Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors

Journal of clinical oncology, 2019-07, Vol.37 (21), p.1838-1840

2019

Volltextzugriff (PDF)

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

Biomedicines, 2023-02, Vol.11 (3), p.732

2023

Volltextzugriff (PDF)

Boosting anticancer immunotherapy through androgen receptor blockade

Cancer cell, 2022-05, Vol.40 (5), p.455-457

2022

Volltextzugriff (PDF)

Macrophages and bone metastasis

The Journal of experimental medicine, 2023-04, Vol.220 (4)

2023

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

Thymic epithelial tumors: From biology to treatment

Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors

Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies

Successful treatment with avapritinib in patient with mucosal metastatic melanoma

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.

Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers

The effect of patient sex on the efficacy and safety of anticancer immunotherapy

Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

Boosting anticancer immunotherapy through androgen receptor blockade

Macrophages and bone metastasis

Suchergebnisse filtern